Leukemia Research

Top Research Topics at Leukemia Research?

Leukemia Research investigates studies in Internal medicine, Cancer research, Immunology, Leukemia and Oncology. The research on Internal medicine tackled can also make contributions to studies in the areas of Gastroenterology, Endocrinology and Surgery. More specifically, the research on Cancer research in the journal is related to Myeloid leukemia.

The studies on Immunology discussed can also contribute to research in the domains of Haematopoiesis and Stem cell. In the journal, Myeloid and Molecular biology are investigated in conjunction with one another to address concerns in Leukemia research. Cell culture, Biochemistry and Cellular differentiation are some topics wherein Molecular biology research discussed in the journal have an impact.

Aside from research in Oncology, the journal also discusses In patient studies. The Bone marrow study featured falls within the larger field of Pathology. Lymphoma is a focus of the Pathology works in the journal.

• Internal medicine (28.97%)
• Cancer research (24.61%)
• Immunology (22.82%)

What are the most cited papers published in the journal?

• Diagnostic criteria and classification of mastocytosis: a consensus proposal (874 citations)
• Establishment of an immature mast cell line from a patient with mast cell leukemia. (672 citations)
• Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcεRI or FcγRI (426 citations)

Research areas of the most cited articles at Leukemia Research:

The most cited publications focus largely on the fields of Immunology, Leukemia, Internal medicine, Cancer research and Myeloid leukemia. Issues in Leukemia were discussed in the most cited papers, taking into consideration concepts from other disciplines like Myeloid, Molecular biology and Pathology. The journal articles explore topics in Internal medicine which can be helpful for research in disciplines like Gastroenterology, Surgery and Oncology.

What topics the last edition of the journal is best known for?

• Internal medicine
• Gene
• Cancer

The previous edition focused in particular on these issues:

The journal facilitates discussions on Internal medicine, Oncology, Cancer research, Myeloid leukemia and Pathogenesis. Leukemia Research investigates Internal medicine research which frequently intersects with Gastroenterology. The journal tackles studies in Transplantation and the interrelated subject of Bridging (networking) to gain insights into Cancer research.

The journal facilitates discussions on Myeloid leukemia that incorporate concepts from other fields like Myeloid and Leukemia. Research in the field of Immunology was used to conduct the presented Pathogenesis study. Immunology research is concerned with Immune system in particular.

The most cited articles from the last journal are:

• Murine double minute 2 inhibition alone or with cytarabine in acute myeloid leukemia: Results from an idasanutlin phase 1/1b study⋆. (5 citations)
• Isatuximab plus pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma according to prior lines of treatment and refractory status: ICARIA-MM subgroup analysis. (3 citations)
• Exosome-derived miR-let-7c promotes angiogenesis in multiple myeloma by polarizing M2 macrophages in the bone marrow microenvironment (2 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Leukemia Research (based on the number of publications) are:

• Pierre Fenaux (196 papers) published 4 papers at the last edition, 3 more than at the previous edition,
• U. Germing (126 papers) published 3 papers at the last edition,
• Hagop M. Kantarjian (105 papers) published 2 papers at the last edition, 1 more than at the previous edition,
• Guillermo Sanz (97 papers) published 2 papers at the last edition, 1 more than at the previous edition,
• Norbert Gattermann (96 papers) published 1 paper at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Leukemia Research (based on the number of publications) are:

• University of Texas MD Anderson Cancer Center (234 papers) published 12 papers at the last edition, 6 more than at the previous edition,
• Mayo Clinic (149 papers) absent at the last edition,
• French Institute of Health and Medical Research (122 papers) published 1 paper at the last edition the same number as at the previous edition,
• Sapienza University of Rome (118 papers) published 1 paper at the last edition,
• Harvard University (116 papers) published 7 papers at the last edition, 3 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 42.46% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 15.86% were posted by at least one author from the top 10 institutions publishing in the journal. Another 4.83% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 11.03% of all publications and 68.28% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

A Closer Look at Careers in Leukemia Research

For those interested in pursuing a career in leukemia research, it's important to understand the educational and professional requirements, especially the critical role that specialized programs play. For instance, becoming a nurse practitioner with a focus in oncology and hematological disorders requires an advanced degree and further certifications. One of the pathways is to start with a Bachelor of Science in Nursing (BSN) followed by a Master's in Nursing (MSN). After acquiring the necessary experience, you may want to specialize in the field of oncology. Choosing this route may lead to becoming a leukemia researcher where you would focus on conditions such as myeloid leukemia, a major topic of cancer research. While the specifics can vary depending upon state and education institution, understanding the details of a typical program can be beneficial. Aspiring nurse practitioners in Wisconsin, for example, can review the nurse practitioner program requirements in Wisconsin as a benchmark. It's enlightening to see the intertwining of several disciplines such as internal medicine, immunology, and cellular differentiation providing a holistic approach to leukemia research. Choosing to invest in this career path not only improves the gap in today's healthcare but also brings us one step closer in improving the survival rates and quality of life for leukemia patients.